Medial pulvinar stimulation for focal drug-resistant epilepsy: interim 12-month results of the PULSE study
Preliminary results suggest that PuM DBS may offer a promising therapeutic option for reducing seizure severity and improving quality of life and cognitive functions in patients with drug-resistant epilepsy. Despite the small sample size and the presence of serious adverse events, the findings warrant further investigation with larger cohorts to confirm these trends and optimize the treatment protocol.
Authors
- Francesca Pizzo (ORCID: https://orcid.org/0000-0001-6345-1288)
- Fabrice Bartoloméi (ORCID: https://orcid.org/0000-0002-1678-0297)
- Romain Carron (ORCID: https://orcid.org/0000-0002-4723-7406)
- Virginie Laguitton
- Bernard Giusiano (ORCID: https://orcid.org/0000-0002-5300-7738)
- A. Clément (ORCID: https://orcid.org/0009-0001-0580-9453)
Institutions
- Inserm (FR)
- Institut de Neurosciences des Systèmes (FR)
- Hôpital de la Timone (FR)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.3389/fneur.2024.1480819
- Citations
- 15
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.54
Funders
- Ministry of Health, British Columbia